Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, March 16, 2021
[ Tue, Mar 16th 2021
] - WOPRAI
[ Tue, Mar 16th 2021
] - WOPRAI
[ Tue, Mar 16th 2021
] - WOPRAI
[ Tue, Mar 16th 2021
] - WOPRAI
[ Tue, Mar 16th 2021
] - WOPRAI
[ Tue, Mar 16th 2021
] - WOPRAI
[ Tue, Mar 16th 2021
] - WOPRAI
[ Tue, Mar 16th 2021
] - WOPRAI
[ Tue, Mar 16th 2021
] - WOPRAI
[ Tue, Mar 16th 2021
] - WOPRAI
[ Tue, Mar 16th 2021
] - WOPRAI
Mon, March 15, 2021
[ Mon, Mar 15th 2021
] - WOPRAI
[ Mon, Mar 15th 2021
] - WOPRAI
[ Mon, Mar 15th 2021
] - WOPRAI
[ Mon, Mar 15th 2021
] - WOPRAI
[ Mon, Mar 15th 2021
] - WOPRAI
[ Mon, Mar 15th 2021
] - WOPRAI
[ Mon, Mar 15th 2021
] - WOPRAI
[ Mon, Mar 15th 2021
] - WOPRAI
[ Mon, Mar 15th 2021
] - WOPRAI
[ Mon, Mar 15th 2021
] - WOPRAI
[ Mon, Mar 15th 2021
] - WOPRAI
[ Mon, Mar 15th 2021
] - WOPRAI
[ Mon, Mar 15th 2021
] - WOPRAI
[ Mon, Mar 15th 2021
] - WOPRAI
David Anderson Maintained (ADNT) at Buy with Increased Target to $60 on, Mar 15th, 2021
David Anderson of Barclays, Maintained "Adient plc" (ADNT) at Buy with Increased Target from $45 to $60 on, Mar 15th, 2021.
David has made no other calls on ADNT in the last 4 months.
There are 4 other peers that have a rating on ADNT. Out of the 4 peers that are also analyzing ADNT, 2 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Armintas Sinkevicius of "Morgan Stanley" Maintained at Hold with Increased Target to $36 on, Monday, February 8th, 2021
- Ryan Brinkman of "JP Morgan" Upgraded from Sell to Hold and Increased Target to $35 on, Friday, January 22nd, 2021
These are the ratings of the 2 analyists that currently disagree with David
- Dan Levy of "Credit Suisse" Maintained at Buy with Increased Target to $54 on, Wednesday, February 10th, 2021
- John Murphy of "B of A Securities" Downgraded from Strong Buy to Sell on, Tuesday, November 17th, 2020
